Current knowledge and future perspectives of exosomes as nanocarriers in diagnosis and treatment of diseases

Z Zou, H Li, G Xu, Y Hu, W Zhang… - International Journal of …, 2023 - Taylor & Francis
Exosomes, as natural nanocarriers, characterized with low immunogenicity, non-cytotoxicity
and targeted delivery capability, which have advantages over synthetic nanocarriers …

[HTML][HTML] Exosome nanovesicles: a potential carrier for therapeutic delivery

VP Chavda, A Pandya, L Kumar, N Raval, LK Vora… - Nano Today, 2023 - Elsevier
Exosomes are small nanosized biovesicles that form when multivesicular bodies and the
plasma membrane fuse and are released into the surrounding body fluids. They are best …

Exosomes harnessed as nanocarriers for cancer therapy-current status and potential for future clinical applications

TU Wani, R Mohi-Ud-Din, RH Mir… - Current molecular …, 2021 - ingentaconnect.com
Exosomes are nano structured (50-90 nm) vesicles that originate from endosomal
compartment of eukaryotic cells and are secreted into extracellular matrix. In recent years …

Exosomes as cutting-edge therapeutics in various biomedical applications: an update on engineering, delivery, and preclinical studies

F Mehryab, F Taghizadeh, N Goshtasbi, F Merati… - Biochimie, 2023 - Elsevier
Exosomes are cell-derived nanovesicles, circulating in different body fluids, and acting as an
intercellular mechanism. They can be purified from culture media of different cell types and …

[HTML][HTML] Exosomes: biological pharmaceutical nanovectors for theranostics

SC Thomas, JW Kim, GM Pauletti… - … in bioengineering and …, 2022 - frontiersin.org
Exosomes are natural cell-derived nanovesicles of endocytic origin that enable cellular
crosstalk by transferring encapsulated molecular cargos across biological barriers, thereby …

Engineered Exosomes as Theranostic Platforms for Cancer Treatment

X Yang, X Xie, S Liu, W Ma, Z Zheng… - … Science & Engineering, 2023 - ACS Publications
Tremendous progress in nanotechnology and nanomedicine has made a significant positive
effect on cancer treatment by integrating multicomponents into a single multifunctional …

Exosomes as new generation vehicles for drug delivery systems

N Dilsiz - Journal of Drug Delivery Science and Technology, 2024 - Elsevier
Exosomes are the smallest subtype of mobile extracellular vesicles (EVs), and round sacs
with a diameter between 30 and 120 nm are released by almost all cell types into the …

Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications

MN Huda, M Nafiujjaman, IG Deaguero… - ACS biomaterials …, 2021 - ACS Publications
Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They …

Targeted exosome-based nanoplatform for new-generation therapeutic strategies

W Yin, H Ma, Y Qu, S Wang, R Zhao, Y Yang… - Biomedical …, 2024 - iopscience.iop.org
Abstract Exosomes, typically 30–150 nm in size, are lipid-bilayered small-membrane
vesicles originating in endosomes. Exosome biogenesis is regulated by the coordination of …

Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives

S Sen, J Xavier, N Kumar, MZ Ahmad, OP Ranjan - 3 Biotech, 2023 - Springer
Abstract Exosomes are nanosized (size~ 30–150 nm) natural vesicular structures released
from cells by physiological processes or pathological circumstances. Exosomes are growing …